SR One Capital Management

Major shareholder at ADARx Pharmaceuticals · 10 reported transactions in 2 companies · latest trade Sep 28, 2026

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −22.7%, S&P 500 −2.3% over the same days.

1 more is too recent to measure.

Their trades


ADARx PharmaceuticalsADRX	Bought $7.05M · 414,814 shares	Sep 28, 2026	S&P 500 +0.9%thru Oct 29
ADARx PharmaceuticalsADRX	Bought $10.07M · 592,593 shares	Sep 28, 2026	S&P 500 +0.9%thru Oct 29
Zenas BiopharmaZBIO	Bought $1.2M · 63,157 shares	Oct 9, 2025	S&P 500 +15.1%thru Oct 29
Zenas BiopharmaZBIO	Bought $1.2M · 63,158 shares	Oct 9, 2025	S&P 500 +15.1%thru Oct 29

BoughtADARx Pharmaceuticals

Sep 28, 2026 · ADRX

$7.05M

S&P 500 +0.9%thru Oct 29

BoughtADARx Pharmaceuticals

Sep 28, 2026 · ADRX

$10.07M

S&P 500 +0.9%thru Oct 29

BoughtZenas Biopharma

Oct 9, 2025 · ZBIO

$1.2M

S&P 500 +15.1%thru Oct 29

BoughtZenas Biopharma

Oct 9, 2025 · ZBIO

$1.2M

S&P 500 +15.1%thru Oct 29

10 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.